The Effect of Cannabis-Based Medicine on Neuropathic Pain and Spasticity in Patients with Multiple Sclerosis and Spinal Cord Injury: Study Protocol of a National Multicenter Double-Blinded, Placebo-Controlled Trial

Disease or acquired damage to the central nervous system frequently causes disabling spasticity and central neuropathic pain (NP), both of which are frequent in multiple sclerosis (MS) and spinal cord injury (SCI). Patients with MS and SCI often request treatment with cannabis-based medicine (CBM)....

Descripción completa

Detalles Bibliográficos
Autores principales: Hansen, Julie Schjødtz, Hansen, Rikke Middelhede, Petersen, Thor, Gustavsen, Stefan, Oturai, Annette Bang, Sellebjerg, Finn, Sædder, Eva Aggerholm, Kasch, Helge, Rasmussen, Peter Vestergaard, Finnerup, Nanna Brix, Svendsen, Kristina Bacher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465969/
https://www.ncbi.nlm.nih.gov/pubmed/34573231
http://dx.doi.org/10.3390/brainsci11091212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465969/
https://www.ncbi.nlm.nih.gov/pubmed/34573231
http://dx.doi.org/10.3390/brainsci11091212

Ejemplares similares